does novo nordisk have a patent on semaglutide New Delhi, March 19, 2026 – Friday, the key on semaglutide—the active molecule in Nordisk's blockbuster drugs Ozempic and Wegovy—expired in India, marking pivotal shift in the country's Novo Nordisk patent expiry opens
Pay in 4 interest-free payments of $7.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26



























